JM
Therapeutic Areas
IMU Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Discovery of Immune Signatures | Immune-related diseases | Discovery |
| Drug Discovery & Development Partnerships | Various | Discovery/Pre-clinical |
| Immune-Driven Precision Medicine | Various | Discovery |
Leadership Team at IMU Biosciences
JB
John Baker, PhD
Chief Executive Officer
AL
Adam Laing, PhD
Co-founder & Chief Scientific Officer
TH
Thomas Hayday, PhD
Co-founder & Chief Research Officer
MC
Mario Cantero, MBA
Co-founder & Chief Operating Officer
VS
Victoria Statham, PhD
Chief Legal Officer